Liver stiffness measurement among patients with chronic hepatitis b and c: Results from a 5-year prospective study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Christiansen, Karen M ^a   Ssner, Belinda K Mö ^a   Hansen, Janne F ^a   Jarnbjer, Erik F ^a   Pedersen, Court ^a   Christensen, Peer B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CAUSE OF DEATH; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ELASTOGRAPH; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER; LIVER BIOPSY; LIVER FIBROSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIXED INFECTION; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PROSPECTIVE STUDY; REGISTER; LIVER CIRRHOSIS; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; SURVIVAL; VIROLOGY;

ADULT; DISEASE PROGRESSION; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 84918581991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111912     Document Type: Article

References (40)

1. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology 49: 1017-1044. 10.1002/hep.22742 [doi].
2. Manning DS, Afdhal NH (2008) Diagnosis and quantitation of fibrosis. Gastroenterology 134: 1670-1681. S0016-5085(08)00425-3 [pii];10.1053/j. gastro.2008.03.001 [doi].
3. Castera L (2012) Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142: 1293-1302. S0016-5085(12)00230-2 [pii];10.1053/j.gastro.2012.02.017 [doi].
4. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, et al. (2003) Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29: 1705-1713.
5. Berzigotti A, De GA, Vukotic R, Siramolpiwat S, Abraldes JG, et al. (2013) Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension. PLoS One 8: E58742. 10.1371/journal.pone.0058742 [doi]; PONE-D-12-38729 [pii].
6. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, et al. (2007) Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14: 360-369.
7. Arena U, Lupsor PM, Stasi C, Moscarella S, Assarat A, et al. (2013) Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 58: 65-72. 10.1002/hep.26343 [doi].
8. Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, et al. (2010) Liver stiffness is directly influenced by central venous pressure. J Hepatol 52: 206-210. S0168-8278(09)00794-6 [pii]; doi10.1016/j.jhep.2009.11.018.
9. Ganne-Carrie N, Ziol M, de Lédinghen V, Douvin C, Marcellin P, et al. (2006) Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 44: 1511-1517.
10. Colombo S, Belloli L, Zaccanelli M, Badia E, Jamoletti C, et al. (2011) Normal liver stiffness and its determinants in healthy blood donors. Dig Liver Dis 43: 231-236. S1590-8658(10)00259-8 [pii]; doi10.1016/j.dld.2010.07.008.
11. Roulot D, Czernichow S, Le CH, Costes JL, Vergnaud AC, et al. (2008) Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome. J Hepatol 48: 606-613.
12. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, et al. (2011) Transient elastography as a screening tool for liver fibrosis and cirrhosis in a communitybased population aged over 45 years. Gut 60: 977-984. gut.2010.221382 [pii]; doi10.1136/gut.2010.221382.
13. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, et al. (2008) Performance of transient elastography for the staging of liver fibrosis: A metaanalysis. Gastroenterology 134: 960-974. S0016-5085(08)00108-X [pii]; doi10.1053/j.gastro.2008.01.034.
14. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, et al. (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. J Hepatol 54: 650-659. S0168- 8278(10)00825-1 [pii]; doi10.1016/j.jhep.2010.07.033.
15. Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, et al. (2010) Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol 53: 1013-1021. S0168-8278(10)00692-6 [pii]; doi10.1016/j.jhep.2010.05.035.
16. Christensen PB, Clausen MR, Krarup H, Laursen AL, Schlichting P, et al. (2012) Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011. Dan Med J 59: C4465. C4465 [pii].
17. Castera L, Pinzani M, Bosch J (2012) Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 56: 696-703. S0168- 8278(11)00553-8 [pii]; doi10.1016/j.jhep.2011.07.005.
18. Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371: 838-851. S0140- 6736(08)60383-9 [pii]; doi10.1016/S0140-6736(08)60383-9.
19. Ydreborg M, Lisovskaja V, Lagging M, Christensen PB, Langeland N, et al. (2014) A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis. PLoS One 9 e93601. doi:10.1371/journal.pone.0093601.
20. Mehta SH, Kirk GD, Astemborski J, Sulkowski MS, Afdhal NH, et al. (2012) Stability of liver fibrosis among HCV-infected injection drug users. Antivir Ther 17: 813-821. doi10.3851/IMP2085.
21. Fransen van de Putte DE, Fischer K, de Knegt RJ, Posthouwer D, van Erpecum KJ, et al. (2011) Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders. Haemophilia 17: E975-e980. doi10.1111/j.1365-2516.2011.02542.x.
22. Seeff LB (2009) The history of the "natural history" of hepatitis C (1968-2009). Liver Int 29 Suppl 1: 89-99. LIV1927 [pii]; doi 10.1111/j.1478-3231.2008.01927.x.
23. Moessner BK, Jorgensen TR, Skamling M, Vyberg M, Junker P, et al. (2011) Outreach screening of drug users for cirrhosis with transient elastography. Addiction 106: 970-976. doi10.1111/j.1360-0443.2010.03246.x.
24. Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, et al. (2003) Progression of fibrosis in chronic hepatitis C. Gastroenterology 124: 97-104.
25. Marcellin P, Asselah T, Boyer N (2002) Fibrosis and disease progression in hepatitis C. Hepatology 36: S47-S56.
26. McHutchison J, Goodman Z, Patel K, Makhlouf H, Rodriguez-Torres M, et al. (2010) Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. Gastroenterology 138: 1365-73, 1373. S0016-5085(09)02111-8 [pii]; doi10.1053/j.gastro.2009.12.003.
27. Dam FA, de Schaffalitzky Muckadell OB, Touborg LA (2012) Incidence, etiology and mortality of cirrhosis: A population-based cohort study. Scand J Gastroenterol 47: 702-709. doi10.3109/00365521.2012.661759.
28. Klibansky DA, Mehta SH, Curry M, Nasser I, Challies T, et al. (2012) Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat 19: E184-e193. doi10.1111/j.1365-2893.2011.01493.x.
29. Missiha SB, Ostrowski M, Heathcote EJ (2008) Disease progression in chronic hepatitis C: Modifiable and nonmodifiable factors. Gastroenterology 134: 1699-1714. S0016-5085(08)00348-X [pii]; doi10.1053/j.gastro.2008.02.069.
30. Asrani SK, Kamath PS (2013) Natural history of cirrhosis. Curr Gastroenterol Rep 15: 308. doi10.1007/s11894-012-0308-y.
31. Vergniol J, Foucher J, Terrebonne E, Bernard PH, Le BB, et al. (2011) Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 140: 1970-9, 1979. S0016- 5085(11)00270-8 [pii]; doi10.1053/j.gastro.2011.02.058.
32. Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, et al. (2012) Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 32: 612-621. doi10.1111/j.1478-3231.2011.02660.x.
33. Jung KS, Kim SU, Ahn SH, Park YN, Kim DY, et al. (2011) Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 53: 885-894. doi10.1002/hep.24121.
34. Kim SU, Lee JH, Kim DY, Ahn SH, Jung KS, et al. (2012) Prediction of liverrelated events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. Plos One 7: E36676. doi10.1371/journal.pone.0036676; PONE-D-12-00848 [pii].
35. de Lédinghen V, Vergniol J, Barthe C, Foucher J, Chermak F, et al. (2013) Noninvasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther 37: 979-988. doi10.1111/apt.12307.
36. Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, et al. (2013) Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 11: 1573-1584. S1542-3565(13)01167-1 [pii]; doi10.1016/j.cgh.2013.07.034.
37. Fung J, Lai CL, Wong DK, Seto WK, Hung I, et al. (2011) Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year followup study. J Viral Hepat 18: E200-e205. doi10.1111/j.1365-2893.2010.01428.x.
38. Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, et al. (2014) Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest) and transient elastography (FibroScan(R)). J Hepatol 60: 706-714. S0168- 8278(13)00817-9 [pii]; doi10.1016/j.jhep.2013.11.016.
39. Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Loberg EM, et al. (2013) Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver. Scand J Gastroenterol 48: 93-100. doi10.3109/00365521.2012.746389.
40. de Lédinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, et al. (2012) Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan(R). J Hepatol 56: 833-839. S0168-8278(11)00855-5 [pii]; doi10.1016/j.jhep.2011.10.017.